ABSTRACT:
Quality of Processed Blood for Autotransfusion. JECT March 2000; 32: 11-9. Shulman, et al.
The authors evaluate the quality of processed blood using several parameters and demonstrate that the C.A.T.S System has a high washout efficiency and produces consistently high HCT at high flow rates.
|
ABSTRACT:
Continuous-Flow Cell Saver Reduces Cognitive Decline in Elderly Patients After Coronary Bypass Surgery. Circulation. 2007;116:1888-1895. Djaiani et al.
In this 226-patient randomized, double-blinded study, the use of the Fresenius C.A.T.S System to process shed blood showed less post-operative cognitive dysfunction than those using unprocessed shed blood.
|
ABSTRACT:
Intraoperative Autotransfusion in Small Children: An In-vitro Investigation to Study its Feasibility. Anesth Analg, April 1999; 88(4): 763-6. Booke, et al.
This in-vitro study demonstrates the ability of the Fresenius C.A.T.S System to produce high quality HCT independent of blood volume suggesting the feasibility of IAT in small children.
|
ABSTRACT:
Qualitative Assessment of Blood Washing with the Continuous Autologous Transfusion System (CATS). Int J Art Org, April 1997; 20: 234-9. Walpoth, et al.
In this prospective study, the authors consistently found HCT of 62% and elimination rates greater than 93% for plasma components using the Fresenius C.A.T.S System.
|
ABSTRACT:
Blood Separation with Two Different Autotransfusion Devices: Effects on Blood Cell Quality and Coagulation Variables. Int. J Artif Organs, Dec 1998; 2: 820-4. Rosalski, et al.
The authors compare the Fresenius C.A.T.S System with another device and found that C.A.T.S had a higher platelet recovery rate and higher platelet concentration.
|